Manager TitleAgeSince
Chief Executive Officer 49 2025-05-30
Director of Finance/CFO 61 2025-05-30
Sales & Marketing 53 2023-12-31
Director TitleAgeSince
Director/Board Member 62 2019-12-31
Chairman 42 2025-05-31
Director/Board Member 75 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average -2.28%+0.28%+9.51%+16.66% 66.7B
Weighted average by Cap. +1.53%+1.90%+1.97%+17.88%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock